Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Non Operating Income (2018 - 2025)

Dna X filings provide 8 years of Non Operating Income readings, the most recent being -$562000.0 for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 225.17% to -$562000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$902000.0, a 466.67% decrease, with the full-year FY2025 number at -$902000.0, down 466.67% from a year prior.
  • Non Operating Income hit -$562000.0 in Q4 2025 for Dna X, down from -$161000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $601000.0 in Q4 2022 to a low of -$562000.0 in Q4 2025.
  • Median Non Operating Income over the past 5 years was -$75500.0 (2023), compared with a mean of -$20250.0.
  • Biggest five-year swings in Non Operating Income: tumbled 2166.67% in 2021 and later soared 45000.0% in 2024.
  • Dna X's Non Operating Income stood at $400000.0 in 2021, then surged by 50.25% to $601000.0 in 2022, then crashed by 100.17% to -$1000.0 in 2023, then soared by 45000.0% to $449000.0 in 2024, then tumbled by 225.17% to -$562000.0 in 2025.
  • The last three reported values for Non Operating Income were -$562000.0 (Q4 2025), -$161000.0 (Q3 2025), and -$215000.0 (Q2 2025) per Business Quant data.